|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Mar 31, 2014
|
|
|---|---|---|---|
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation, depletion and amortization of property and equipment | |||
| Exploration expenses | |||
| Stock-based compensation | |||
| Bad debt expense | |||
| Amortization of deferred loan costs and other | |||
| Accretion of end-of-term charge | |||
| Unrealized gain on change in fair value of commodity derivatives | |||
| Write-off of deferred offering costs | |||
| Gain on change in fair value of warrant liabilities | |||
| Increase in fair value of Trust Fund | |||
| Accretion of discount on long-term debt | |||
| Loss on disposal of property and equipment | |||
| Gain on the sale of Etzold | |||
| Settlement of asset retirement obligations | |||
| Impairment of oil and gas properties | |||
| Changes in operating assets and liabilities: | |||
| Accounts receivable | |||
| Prepaid expenses and other current assets | |||
| Inventory | |||
| Accounts payable | |||
| Deferred revenues | |||
| Accrued expenses | |||
| Deferred legal fees | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities: | |||
| Cash contributed to Trust Fund | |||
| Purchase of proved oil and gas property | |||
| Purchase of other property and equipment | |||
| Proceeds from the sale of long-term commodity derivatives | |||
| Proceeds from the sale of Etzold | |||
| Net cash used in investing activities | |||
| Cash flows from financing activities: | |||
| Proceeds from shareholder's loans | |||
| Proceeds from issuance of common stock, preferred stock and preferred warrants | |||
| Proceeds from note and advances payable to affiliate | |||
| Proceeds from issuance of warrants | |||
| Portion of net proceeds from sale of units through Public offering allocable to shares subject to possible redemption | |||
| Net proceeds from sale of units through public offering allocable to shareholders' equity | |||
| Proceeds from issuance of long-term debt | |||
| Proceeds from exercise of warrants and stock options | |||
| Proceeds from merger with Infinity Corp. including private placement of common stock | |||
| Payments on long-term debt | |||
| Payments for deferred offering costs | |||
| Payments for deferred loan costs | |||
| Net cash provided by (used in) financing activities | |||
| Net increase (decrease) in cash and cash equivalents | |||
| Cash and cash equivalents, beginning of period | |||
| Cash and cash equivalents, end of period | |||
| Non-cash financing and investing activities: | |||
| Deferred offering costs included in accrued offering costs | |||
| Deferred legal fees | |||
| Adjustment for warrant liability in connection with the public offering | |||
| Contribution of capital equal to fair value of derivative due to termination of derivative liability | |||
| Fair value of preferred stock and preferred warrants in excess of proceeds | |||
| Asset retirement obligation assumed | |||
| Issuance of preferred stock in settlement of accrued expense | |||
| Supplemental cash flow information: | |||
| Interest paid |
Loading...